Visalytics
Visalytics
approved EB-2 (NIW)

Associate Scientist

Biomedical Sciences · Egypt · 2024-01-16

Processing Time
6 days
Decision Date
2024-01-16
Location
Pennsylvania
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to examine signaling pathways in platelets and immune cells to support the development of targeted therapies for autoimmune diseases, allergies, and infectious diseases. Her work focuses on leveraging host defense mechanisms to combat antimicrobial resistance and mitigate the economic impact of immune-related conditions.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The work addresses global health threats like antimicrobial resistance and aligns with WHO Sustainable Development Goals.

2 Well-positioned to Advance the Endeavor Met

The petitioner holds a Ph.D. and has a documented history of influential publications, citations, and NIH-funded research.

3 Waiver Benefit Met

The petitioner's expertise in immune response mechanisms is essential for sustaining US technical leadership in biomedical research.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in basic medical research and a record of 14 peer-reviewed journal publications. Her work garnered 119 citations and she completed 15 peer reviews for reputable journals. Additionally, her research received funding from the National Institutes of Health (NIH) and the National Institute of Allergy and Infectious Diseases (NIAID).

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Pharmaceuticals · Egypt

WeGreened EB-2 (NIW) approved
Tennessee 646 days 2025-11-14
The petitioner proposes to examine immune system dysfunction and its relationship to serious medical conditions to uncover novel immune-targeted treatment strategies. The work focuses on identifying immunological mechanisms that inform the development of new therapeutic strategies for autoimmune disorders, cardiovascular disease, and inflammatory conditions.
View Case

Research Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 354 days 2025-04-03
The petitioner proposes to advance the identification of new therapeutic targets for cancer, autoimmune diseases, and chronic inflammatory conditions using high-throughput technologies like single-cell sequencing. Her work focuses on examining T cell behavior within tumor microenvironments and immune responses to vaccines and cancer treatments to develop cost-effective strategies for immune modulation.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Ohio 90 days 2025-01-24
The petitioner proposes to continue his research into the role of immune cells in human diseases, specifically focusing on autoimmunity and tumors. His work aims to develop novel immunotherapies for Diffuse Intrinsic Pontine Glioma (DIPG) and identify new therapeutic targets to improve treatments for cancer and autoimmune conditions.
View Case

Research Scientist

Biotechnology · Slovenia

WeGreened EB-2 (NIW) approved
New York 64 days 2025-02-24
The petitioner proposes to advance the development of robust immunotherapies designed to overcome contemporary limitations such as impaired cell function and disease resistance. Her work focuses on elucidating novel molecular mechanisms of immune cells to improve patient outcomes in cancer care and autoimmune disease management.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Egypt

Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-01-16.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 6 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Egypt All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist